Legacy Capital Group California, Inc. Gilead Sciences, Inc. Transaction History
Legacy Capital Group California, Inc.
- $287 Billion
- Q1 2025
A detailed history of Legacy Capital Group California, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 5,967 shares of GILD stock, worth $639,662. This represents 0.23% of its overall portfolio holdings.
Number of Shares
5,967
Previous 6,027
1.0%
Holding current value
$639,662
Previous $557 Million
20.1%
% of portfolio
0.23%
Previous 0.17%
Shares
9 transactions
Others Institutions Holding GILD
# of Institutions
2,288Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$12.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.6 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.38 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.85 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.74 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $134B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...